Hisamitsu Pharmaceutical Co., Inc. (4530.T)
JPY 4437.0
(2.05%)
JPY 4437.0
(2.05%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 13.96 Billion JPY | 18.97% |
| 2022 | 11.74 Billion JPY | 21.58% |
| 2021 | 9.65 Billion JPY | 4.41% |
| 2020 | 9.25 Billion JPY | -50.52% |
| 2019 | 18.69 Billion JPY | -2.66% |
| 2018 | 19.2 Billion JPY | 0.44% |
| 2017 | 19.11 Billion JPY | -6.26% |
| 2016 | 20.39 Billion JPY | 14.68% |
| 2015 | 17.78 Billion JPY | -5.32% |
| 2014 | 18.78 Billion JPY | -12.05% |
| 2013 | 21.35 Billion JPY | 13.55% |
| 2012 | 18.8 Billion JPY | 2.01% |
| 2011 | 18.43 Billion JPY | -12.01% |
| 2010 | 20.95 Billion JPY | 13.75% |
| 2009 | 18.42 Billion JPY | -3.65% |
| 2008 | 19.12 Billion JPY | 2.45% |
| 2007 | 18.66 Billion JPY | 17.77% |
| 2006 | 15.84 Billion JPY | 9.68% |
| 2005 | 14.44 Billion JPY | 12.23% |
| 2004 | 12.87 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 4.31 Billion JPY | -10.0% |
| 2024 Q1 | 4.78 Billion JPY | 157.56% |
| 2023 Q1 | 4.04 Billion JPY | 82.39% |
| 2023 Q2 | 4.36 Billion JPY | 7.88% |
| 2023 Q4 | 1.85 Billion JPY | -49.66% |
| 2023 FY | 13.96 Billion JPY | 18.97% |
| 2023 Q3 | 3.69 Billion JPY | -15.45% |
| 2022 Q1 | 1.63 Billion JPY | -52.59% |
| 2022 FY | 11.74 Billion JPY | 21.58% |
| 2022 Q2 | 4.87 Billion JPY | 198.77% |
| 2022 Q4 | 2.22 Billion JPY | -26.44% |
| 2022 Q3 | 3.01 Billion JPY | -38.07% |
| 2021 Q4 | 3.44 Billion JPY | 182.89% |
| 2021 Q1 | 2.36 Billion JPY | -33.05% |
| 2021 Q2 | 2.64 Billion JPY | 11.77% |
| 2021 FY | 9.65 Billion JPY | 4.41% |
| 2021 Q3 | 1.21 Billion JPY | -53.94% |
| 2020 Q3 | 2.02 Billion JPY | -43.32% |
| 2020 FY | 9.25 Billion JPY | -50.52% |
| 2020 Q1 | 113 Million JPY | -96.55% |
| 2020 Q2 | 3.58 Billion JPY | 3068.14% |
| 2020 Q4 | 3.52 Billion JPY | 73.88% |
| 2019 Q3 | 7.87 Billion JPY | 39.7% |
| 2019 FY | 18.69 Billion JPY | -2.66% |
| 2019 Q1 | 1.91 Billion JPY | -67.44% |
| 2019 Q2 | 5.63 Billion JPY | 194.56% |
| 2019 Q4 | 3.27 Billion JPY | -58.41% |
| 2018 Q3 | 4.17 Billion JPY | -26.9% |
| 2018 FY | 19.2 Billion JPY | 0.44% |
| 2018 Q1 | 3.45 Billion JPY | 5.28% |
| 2018 Q4 | 5.87 Billion JPY | 40.85% |
| 2018 Q2 | 5.7 Billion JPY | 65.3% |
| 2017 Q2 | 5.71 Billion JPY | 55.47% |
| 2017 Q1 | 3.67 Billion JPY | 78.78% |
| 2017 FY | 19.11 Billion JPY | -6.26% |
| 2017 Q4 | 3.27 Billion JPY | -49.19% |
| 2017 Q3 | 6.45 Billion JPY | 12.99% |
| 2016 Q1 | 4.52 Billion JPY | 83.66% |
| 2016 Q4 | 2.05 Billion JPY | -77.3% |
| 2016 FY | 20.39 Billion JPY | 14.68% |
| 2016 Q3 | 9.05 Billion JPY | 90.33% |
| 2016 Q2 | 4.75 Billion JPY | 5.03% |
| 2015 Q2 | 5.84 Billion JPY | 65.23% |
| 2015 Q4 | 2.46 Billion JPY | -58.5% |
| 2015 Q3 | 5.94 Billion JPY | 1.73% |
| 2015 FY | 17.78 Billion JPY | -5.32% |
| 2015 Q1 | 3.53 Billion JPY | -17.94% |
| 2014 FY | 18.78 Billion JPY | -12.05% |
| 2014 Q4 | 4.3 Billion JPY | -12.12% |
| 2014 Q3 | 4.9 Billion JPY | -12.09% |
| 2014 Q2 | 5.57 Billion JPY | 39.47% |
| 2014 Q1 | 3.99 Billion JPY | 84.32% |
| 2013 Q3 | 5.5 Billion JPY | -10.7% |
| 2013 Q4 | 2.16 Billion JPY | -60.61% |
| 2013 FY | 21.35 Billion JPY | 13.55% |
| 2013 Q1 | 7.51 Billion JPY | 98.36% |
| 2013 Q2 | 6.16 Billion JPY | -17.93% |
| 2012 Q3 | 5.68 Billion JPY | -0.59% |
| 2012 Q2 | 5.72 Billion JPY | 58.34% |
| 2012 FY | 18.8 Billion JPY | 2.01% |
| 2012 Q4 | 3.78 Billion JPY | -33.39% |
| 2012 Q1 | 3.61 Billion JPY | -4.16% |
| 2011 Q2 | 4.32 Billion JPY | 56.96% |
| 2011 Q3 | 7.58 Billion JPY | 75.12% |
| 2011 Q4 | 3.77 Billion JPY | -50.27% |
| 2011 FY | 18.43 Billion JPY | -12.01% |
| 2011 Q1 | 2.75 Billion JPY | -35.67% |
| 2010 Q2 | 5.91 Billion JPY | -2.76% |
| 2010 Q1 | 6.08 Billion JPY | 161.83% |
| 2010 Q4 | 4.28 Billion JPY | -8.14% |
| 2010 FY | 20.95 Billion JPY | 13.75% |
| 2010 Q3 | 4.66 Billion JPY | -21.13% |
| 2009 Q2 | 5.17 Billion JPY | 17.65% |
| 2009 Q1 | 4.39 Billion JPY | 0.0% |
| 2009 FY | 18.42 Billion JPY | -3.65% |
| 2009 Q4 | 2.32 Billion JPY | -64.41% |
| 2009 Q3 | 6.53 Billion JPY | 26.26% |
| 2008 FY | 19.12 Billion JPY | 2.45% |
| 2007 FY | 18.66 Billion JPY | 17.77% |
| 2006 FY | 15.84 Billion JPY | 9.68% |
| 2005 FY | 14.44 Billion JPY | 12.23% |
| 2004 FY | 12.87 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 3.2 Billion JPY | -335.85% |
| Takeda Pharmaceutical Company Limited | 144.06 Billion JPY | 90.304% |
| Sumitomo Pharma Co., Ltd. | -314.96 Billion JPY | 104.435% |
| Shionogi & Co., Ltd. | 162.03 Billion JPY | 91.379% |
| Wakamoto Pharmaceutical Co.,Ltd. | 108.95 Million JPY | -12720.419% |
| Nippon Shinyaku Co., Ltd. | 25.85 Billion JPY | 45.963% |
| Kaken Pharmaceutical Co., Ltd. | 8.02 Billion JPY | -74.069% |
| Eisai Co., Ltd. | 42.4 Billion JPY | 67.06% |
| Morishita Jintan Co., Ltd. | 697 Million JPY | -1904.161% |
| Mochida Pharmaceutical Co., Ltd. | 4.54 Billion JPY | -207.214% |
| Fuso Pharmaceutical Industries,Ltd. | 1.37 Billion JPY | -914.452% |
| Nippon Chemiphar Co., Ltd. | -180 Million JPY | 7860.556% |
| Tsumura & Co. | 16.7 Billion JPY | 16.388% |
| Kissei Pharmaceutical Co., Ltd. | 11.16 Billion JPY | -25.17% |
| Torii Pharmaceutical Co., Ltd. | 4.11 Billion JPY | -239.136% |
| Towa Pharmaceutical Co., Ltd. | 16.17 Billion JPY | 13.628% |
| Fuji Pharma Co., Ltd. | 3.43 Billion JPY | -306.667% |
| Zeria Pharmaceutical Co., Ltd. | 7.73 Billion JPY | -80.682% |
| KYORIN Holdings, Inc. | 5.32 Billion JPY | -162.477% |
| Taiko Pharmaceutical Co.,Ltd. | -4.89 Billion JPY | 385.431% |
| Daito Pharmaceutical Co.,Ltd. | 3.29 Billion JPY | -323.945% |
| SymBio Pharmaceuticals Limited | -1.96 Billion JPY | 811.681% |
| MedRx Co., Ltd | -932 Million JPY | 1598.82% |
| Mizuho Medy Co.,Ltd. | 3.77 Billion JPY | -270.114% |
| Solasia Pharma K.K. | -1.11 Billion JPY | 1356.205% |
| Modalis Therapeutics Corporation | -2.39 Billion JPY | 684.032% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 7.54 Billion JPY | -85.142% |
| Sawai Group Holdings Co., Ltd. | 13.69 Billion JPY | -2.001% |
| Cyfuse Biomedical K.K. | -589.21 Million JPY | 2470.798% |
| Toho Holdings Co., Ltd. | 20.65 Billion JPY | 32.376% |
| Koa Shoji Holdings Co.,Ltd. | 2.94 Billion JPY | -374.114% |